Family Med Medical News about Parkinson Disease

Become a Member Today!
Register

Most Viewed Abstracts

1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

2. Omega-3 fatty acids for bipolar disorder

3. Is folic acid good for everyone

4. ACS Releases Guidelines for HPV Vaccination

5. Vitamin D - A review Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Use of drugs with anticholinergic effect and impact on cognition in Parkinson’s disease: A cohort study
Journal of Neurology, Neurosurgery, and Psychiatry , 10/08/09

Ehrt U et al. – The findings suggest that there is an association between the use of drugs with anticholinergic properties and cognitive decline in PD. This may provide an important opportunity for clinicians to avoid increasing progression of cognitive decline by avoiding such drugs if possible. Increased awareness by clinicians is required about the classes of drugs that have anticholinergic properties.

<< Previous
Comparative analysis of gait and speech in Parkinson’s disease:...

Next >>
Protein microarrays identify antibodies to protein kinase C[zeta]...

Widely Used Cholesterol-lowering Drug May Prevent Progression Of Parkinsons Disease
ScienceDaily, 11/10/09 Relevance Score: 70%

Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia
Brain, 10/30/09 Relevance Score: 70%

Effects of optimism/pessimism and locus of control on disability and quality of life in Parkinson's disease
Parkinsonism & Related Disorders, 10/29/09 Relevance Score: 69%

Sleep disturbances in Malaysian patients with Parkinson's disease using polysomnography and PDSS
Parkinsonism & Related Disorders, 10/29/09 Relevance Score: 69%

Condition Raises Parkinsons Risk 5-Fold
Ivanhoe, 10/27/09 Relevance Score: 69%